Ë¿¹ÏÊÓƵ

Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY

v3.20.2
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
Additional Paid-In Capital
Treasury Stock
Accumulated Deficit
Beginning balance at Apr. 30, 2018 $ 33,733,591 $ 18,334 $ 66,557,005 $ (70,000) $ (32,771,748)
Beginning balance (in shares) at Apr. 30, 2018 Ìý 18,333,521 Ìý Ìý Ìý
Stock-based compensation 1,190,385 Ìý 1,190,385 Ìý Ìý
Common stock issued for cashless stock options exercised 0 $ 112 (112) Ìý Ìý
Common stock issued for cashless stock options exercised (in shares) Ìý 111,666 Ìý Ìý Ìý
Common stock issued for stock options exercised for cash $ 128,201 $ 56 128,145 Ìý Ìý
Common stock issued for stock options exercised for cash (in shares) 194,276 56,910 Ìý Ìý Ìý
Common stock issued for cashless warrant exercise $ 0 $ 120 (120) Ìý Ìý
Common stock issued for cashless exercise of stock options (in shares) 111,666 119,594 Ìý Ìý Ìý
Common stock issued for warrants exercised for cash $ 100,000 $ 44 99,956 Ìý Ìý
Common stock issued for warrants exercised for cash (in shares) Ìý 43,860 Ìý Ìý Ìý
Warrants issued with debt financing 615,587 Ìý 615,587 Ìý Ìý
Amortization of warrant based cost issued for services 1,713 Ìý 1,713 Ìý Ìý
Purchase of treasury stock, net of broker fees (7,370,000) Ìý Ìý (7,370,000) Ìý
Re-sale of treasury stock, net of broker fees 7,370,000 Ìý Ìý 7,370,000 Ìý
Issuance costs (29,832) Ìý (29,832) Ìý Ìý
Net loss (9,278,217) Ìý Ìý Ìý (9,278,217)
Ending balance at Apr. 30, 2019 26,461,428 $ 18,666 68,562,727 (70,000) (42,049,965)
Ending balance (in shares) at Apr. 30, 2019 Ìý 18,665,551 Ìý Ìý Ìý
Stock-based compensation 2,116,309 Ìý 2,116,309 Ìý Ìý
Amortization of restricted stock issued for service 122,250 Ìý 122,250 Ìý Ìý
Common stock issued for cashless stock options exercised 0 $ 191 (191) Ìý Ìý
Common stock issued for cashless stock options exercised (in shares) Ìý 190,559 Ìý Ìý Ìý
Common stock issued for stock options exercised for cash $ 962,650 $ 278 962,372 Ìý Ìý
Common stock issued for stock options exercised for cash (in shares) 363,334 277,678 Ìý Ìý Ìý
Common stock issued for cashless warrant exercise $ 0 $ 77 (77) Ìý Ìý
Common stock issued for cashless exercise of stock options (in shares) 190,559 76,929 Ìý Ìý Ìý
Amortization of warrant based cost issued for services $ 36,719 Ìý 36,719 Ìý Ìý
Restricted stock issued for services, subject to vesting 0 $ 144 (144) Ìý Ìý
Restricted stock issued for services, subject to vesting (in shares) Ìý 144,803 Ìý Ìý Ìý
Common stock issued for equity raise, net of underwriter costs of $1,222,371 16,044,879 $ 2,415 16,042,464 Ìý Ìý
Common stock issued in equity raise, net of underwriter costs of $1,222,371 (in shares) Ìý 2,415,000 Ìý Ìý Ìý
Issuance costs (51,282) Ìý (51,282) Ìý Ìý
Beneficial conversion feature on Convertible Debt 1,692,309 Ìý 1,692,309 Ìý Ìý
Common stock short swing reclamation 21,760 Ìý 21,760 Ìý Ìý
Net loss (5,659,065) Ìý Ìý Ìý (5,659,065)
Ending balance at Apr. 30, 2020 $ 41,747,957 $ 21,771 $ 89,505,216 $ (70,000) $ (47,709,030)
Ending balance (in shares) at Apr. 30, 2020 Ìý 21,770,520 Ìý Ìý Ìý